Immune responses to influenza vaccinations and viruses among health care personnel

Phase 1

• Conditions: MedDRA version: 20.0Level: LLTClassification code 10059430Term: Influenza immunizationSystem Organ Class: 100000022896; MedDRA version: 20.0Level: LLTClassification code 10022001Term: Influenza (epidemic)System Organ Class: 100000015765; Therapeutic area: Body processes [G] - Immune system processes [G12]

• Registration Number: EUCTR2017-003467-34-FI
• Lead Sponsor: Terveyden ja hyvinvoinnin laitos (THL)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2017-09-07
• Last Update Posted: 23 October 2017

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 1500
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: ;Secondary Objective: ;Primary end point(s):